Market Overview
The global vascular stents market is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases, such as coronary artery and peripheral artery conditions. In 2024, the market reached a valuation of USD 11.2 billion and is projected to escalate to USD 17.5 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.1% during the forecast period. This expansion is attributed to advancements in stent materials and designs, the adoption of minimally invasive procedures, and a growing geriatric population.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019–2024
- Forecast Years: 2025–2033
Vascular Stents Market Key Takeaways
- Market Size & Growth: Valued at USD 11.2 billion in 2024, the market is expected to reach USD 17.5 billion by 2033, growing at a CAGR of 5.1%.
- Regional Leadership: North America leads the market, supported by advanced healthcare infrastructure and high adoption of innovative stent technologies.
- Product Segmentation: Coronary stents dominate the product segment, followed by peripheral vascular stents and EVAR stent grafts.
- Material Trends: Metallic stents, particularly those made from cobalt chromium and stainless steel, are widely used due to their durability and efficacy.
- Delivery Modes: Self-expanding stents are gaining popularity for their adaptability in complex vascular anatomies.
- End-User Insights: Hospitals and cardiac centers are the primary end-users, owing to the availability of specialized care and advanced facilities.
- Technological Advancements: The development of drug-eluting and bioresorbable stents is enhancing patient outcomes and reducing the need for repeat interventions.
Market Growth Factors
Technological Advancements in Stent Design
The vascular stents market is on a remarkable upswing, largely thanks to ongoing technological advancements. The introduction of drug-eluting stents (DES) has truly transformed treatment options by lowering restenosis rates and enhancing long-term outcomes for patients. On top of that, bioresorbable vascular scaffolds (BVS) are stepping into the spotlight as a promising alternative, providing temporary support that gradually dissolves, which helps reduce long-term complications. Innovations in imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are making it easier to place stents accurately, boosting the success rates of these procedures.
Rising Prevalence of Cardiovascular Diseases
The rising rates of cardiovascular diseases (CVDs) around the world are a key factor driving the growth of the vascular stents market. Lifestyle choices such as sedentary habits, poor diets, smoking, and the increasing prevalence of diabetes and obesity are all contributing to the heavy toll of CVDs. As our population ages, the need for effective and minimally invasive treatments, like stenting procedures, is on the rise. In response, healthcare systems are working to broaden access to diagnostic and interventional cardiology services, which is further fueling market expansion.
Government Initiatives and Healthcare Infrastructure Development
Supportive government policies and investments in healthcare infrastructure are giving a significant boost to the vascular stents market. Reimbursement programs and public health initiatives focused on the early detection and treatment of cardiovascular issues are making stenting procedures more accessible to patients. Emerging economies are rapidly developing their healthcare facilities, paving the way for the adoption of cutting-edge medical technologies. Collaborations among governments, healthcare providers, and medical device companies are driving innovation and expanding the availability of vascular stent therapies.
Request for a sample copy of this report: https://www.imarcgroup.com/vascular-stents-market/requestsample
Market Segmentation
By Product Type
- Coronary Stents: Used to treat narrowed or blocked coronary arteries, improving blood flow to the heart muscle.
- Peripheral Vascular Stents: Designed for use in peripheral arteries to restore adequate blood flow to limbs and organs.
- EVAR Stent Grafts: Employed in endovascular aneurysm repair procedures to reinforce weakened sections of the aorta.
By Material
- Metallic Stents:
- Cobalt Chromium: Offers high strength and excellent visibility under imaging.
- Platinum Chromium: Provides superior flexibility and conformability to vessel walls.
- Nickel Titanium (Nitinol): Known for its shape memory and superelastic properties.
- Stainless Steel: Widely used due to its durability and cost-effectiveness.
- Others: Includes polymer-based and bioresorbable materials offering temporary support.
By Mode of Delivery
- Balloon-Expandable Stents: Expanded using a balloon catheter, suitable for precise placement in rigid vessels.
- Self-Expanding Stents: Made from materials that expand on their own, ideal for tortuous or soft vessels.
By End-User
- Hospitals and Cardiac Centers: Primary settings for complex stenting procedures with advanced infrastructure.
- Ambulatory Surgical Centers: Offer outpatient stenting services with shorter recovery times.
Breakup by Region
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Regional Insights
North America is leading the way in the vascular stents market, thanks to its top-notch healthcare system, a high rate of cardiovascular diseases, and a quick embrace of cutting-edge stent technologies. The region’s commitment to research and development, along with supportive reimbursement policies, really boosts the use of vascular stents.
Recent Developments & News
We’re seeing some exciting advancements in the vascular stents market, like the creation of drug-eluting stents that release medication to help prevent arteries from narrowing again. Bioresorbable stents, which dissolve over time after doing their job, are becoming popular for minimizing long-term issues. Plus, the rise of digital health technologies is making it easier to monitor patients and gather data, which improves care after procedures. Partnerships between medical device companies and healthcare providers are driving innovation and broadening market access.
Key Players
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- B. Braun Melsungen AG
- Terumo Corporation
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Vascular Concepts Limited
- C.R. Bard, Inc.
- W.L. Gore & Associates, Inc.
- Endologix, Inc.
- Lombard Medical
- Translumina GmbH
- Jotec GmbH
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=1382&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: +1-631-791-1145
